Atlas Trials

A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib

Clinical trial NCT02115035 · WITHDRAWN

Trial details

NCT number
NCT02115035
Sponsor
University of Arkansas
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-07-01
Primary completion
2017-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.